Latest news
Attovia Therapeutics, Developer of Next‑Generation Biotherapeutics for Immune‑Mediated Diseases, Files for Nasdaq IPO - TradingViewTradingView · Wed, 05 Aug 2026 20:09:00 GMTAttovia Therapeutics Announces Pricing of Upsized Initial Public Offering - GlobeNewswireGlobeNewswire · Wed, 05 Aug 2026 00:50:00 GMT